These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11079010)

  • 1. Redesigned proficiency testing materials improve survey outcomes for prostate-specific antigen. A College of American Pathologists Ligand Assay Survey tool.
    Sokoll LJ; Witte DL; Klee GG; Chan DW
    Arch Pathol Lab Med; 2000 Nov; 124(11):1608-13. PubMed ID: 11079010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production, analysis, and characterization of reference materials for prostate-specific antigen.
    Garg UC; Howanitz JH; Nakamura RM; Plous RH; Eckfeldt JH
    Arch Pathol Lab Med; 1995 Dec; 119(12):1104-8. PubMed ID: 7503657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of fresh frozen serum to proficiency testing material in College of American Pathologists surveys: alpha-fetoprotein, carcinoembryonic antigen, human chorionic gonadotropin, and prostate-specific antigen.
    Schreiber WE; Endres DB; McDowell GA; Palomaki GE; Elin RJ; Klee GG; Wang E
    Arch Pathol Lab Med; 2005 Mar; 129(3):331-7. PubMed ID: 15737027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of free prostate-specific antigen (PSA) after chemical release from the complex with alpha(1)-antichymotrypsin (PSA-ACT).
    Peter J; Unverzagt C; Hoesel W
    Clin Chem; 2000 Apr; 46(4):474-82. PubMed ID: 10759471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disagreement between the Roche Cobas Core and Hybritech TANDEM-E PSA assays when measuring free, complexed and total serum prostate specific antigen.
    Tillyer CR; Konings M; Gobin PT; Iqbal J
    Ann Clin Biochem; 1994 Sep; 31 ( Pt 5)():501-5. PubMed ID: 7530440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new modification of the Chiron ACS assay for total prostate-specific antigen achieves equimolar response characteristics and improves the detection of prostate cancer.
    Oberpenning F; Weining C; Brandt B; De Angelis G; Heinecke A; Hamm M; Stieber P; Hertle L; Schmid HP; Semjonow A
    Clin Chem Lab Med; 2003 Jan; 41(1):90-4. PubMed ID: 12636056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of free prostate-specific antigen on discordant measurement results of assays for total prostate-specific antigen.
    Semjonow A; Oberpenning F; Brandt B; Zechel C; Brandau W; Hertle L
    Urology; 1996 Dec; 48(6A Suppl):10-5. PubMed ID: 8973694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the ratio of free to total prostate-specific antigen on interassay variability in proficiency test samples.
    Fox MP; Reilly AA; Schneider E
    Clin Chem; 1999 Aug; 45(8 Pt 1):1181-9. PubMed ID: 10430783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Issues on standardization of immunoassays for prostate-specific antigen: a review.
    Graves HC
    Clin Invest Med; 1993 Dec; 16(6):415-24. PubMed ID: 7516830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward metrological traceability in the determination of prostate-specific antigen (PSA): calibrating Beckman Coulter Hybritech Access PSA assays to WHO standards compared with the traditional Hybritech standards.
    Stephan C; Kahrs AM; Klotzek S; Reiche J; Müller C; Lein M; Deger S; Miller K; Jung K
    Clin Chem Lab Med; 2008; 46(5):623-9. PubMed ID: 18839463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical performance of the Tandem-R free PSA immunoassay measuring free prostate-specific antigen.
    Woodrum DL; French CM; Hill TM; Roman SJ; Slatore HL; Shaffer JL; York LG; Eure KL; Loveland KG; Gasior GH; Southwick PC; Shamel LB
    Clin Chem; 1997 Jul; 43(7):1203-8. PubMed ID: 9216457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity.
    Finlay JA; Evans CL; Day JR; Payne JK; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Wolfert RL; Rittenhouse HG
    Urology; 1998 May; 51(5):804-9. PubMed ID: 9610595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodological and clinical comparison of the ACS prostate-specific antigen assay and the Tandem-E prostate-specific antigen assay in prostate cancer.
    Schambeck CM; Schmeller N; Stieber P; Jansen HM; Pahl H; Schneider W; Fateh-Moghadam A
    Urology; 1995 Aug; 46(2):195-9. PubMed ID: 7542821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardization of assay methods reduces variability of total PSA measurements: an Irish study.
    Forde JC; Marignol L; Blake O; McDermott T; Grainger R; Crowley VE; Lynch TH
    BJU Int; 2012 Sep; 110(5):644-50. PubMed ID: 22897326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the clinical performance of equimolar- and skewed-response total prostate-specific antigen assays versus complexed and free PSA assays and their ratios in discriminating between benign prostatic hyperplasia and prostate cancer.
    Wians FH; Cheli CD; Balko JA; Bruzek DJ; Chan DW; Sokoll LJ
    Clin Chim Acta; 2002 Dec; 326(1-2):81-95. PubMed ID: 12417099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel immunoassay for the measurement of complexed prostate-specific antigen in serum.
    Allard WJ; Zhou Z; Yeung KK
    Clin Chem; 1998 Jun; 44(6 Pt 1):1216-23. PubMed ID: 9625045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a highly sensitive immunochemiluminometric assay for prostate-specific antigen.
    Klee GG; Preissner CM; Oesterling JE
    Urology; 1994 Jul; 44(1):76-82. PubMed ID: 7518985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin: potential reference material for international standardization of PSA immunoassays.
    Chen Z; Prestigiacomo A; Stamey TA
    Clin Chem; 1995 Sep; 41(9):1273-82. PubMed ID: 7544704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 3 investigational assays for the free form of prostate specific antigen.
    Nixon RG; Meyer GE; Blase AB; Gold MH; Brawer MK
    J Urol; 1998 Aug; 160(2):420-5. PubMed ID: 9679890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining free and total prostate specific antigen assays from different manufacturers: the pitfalls.
    Oberpenning F; Weining C; Brandt B; De Angelis G; Heinecke A; Hamm M; Stieber P; Hertle L; Schmid HP; Semjonow A
    Eur Urol; 2002 Dec; 42(6):577-82; discussion 582. PubMed ID: 12477653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.